about
Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and diseaseAcrolein-mediated conduction loss is partially restored by K⁺ channel blockersBringing CLARITY to gray matter atrophy.Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology.Contribution of pannexin1 to experimental autoimmune encephalomyelitis.Varicella zoster virus and relapsing remitting multiple sclerosis.Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis VirusNeuroprotective effects of testosterone treatment in men with multiple sclerosis.Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis.The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography study.Interactions between oligodendrocyte precursors control the onset of CNS myelination.Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.Transplantation of Pro-Oligodendroblasts, Preconditioned by LPS-Stimulated Microglia, Promotes Recovery After Acute Contusive Spinal Cord Injury.Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
P2860
Q28081607-69BCC023-6A85-4446-8BA6-413FE88EED57Q28829557-6E722D1A-091F-4F0A-8CBF-6A8E063EC293Q30651109-4A3E21ED-EE75-4201-8FF8-74900D588BC3Q33882744-235A6FBD-659F-4D21-A3DC-DB7875644411Q34864822-6D5009E4-3E9E-41AC-9ED1-B6DDB9A65F0BQ35374873-1A232E4A-6C36-4868-99E6-C122ED6B7E63Q36392287-B37EBCFF-3FCC-4ECB-B228-15E1219B6CD7Q37634705-7AC0BFEA-916F-4D71-AAA6-1E13CA74D951Q38446276-CD1AC6B7-E570-477B-8D5B-9FEFD3A61933Q38569263-1D4F2EF5-5E7F-4246-B719-B980131BF9FEQ38783057-FB663658-7ADC-4143-8EC2-082877EFEE31Q40165089-8D7EEC71-CB00-4745-B14E-221A246C9E93Q40622624-1EFA79D1-2599-4B8B-9B08-F156E0F8A941Q42588274-CA506282-A38F-4D06-A0C7-FA9B9B687F4EQ44565890-C3BDCD71-F733-421A-8021-496CFA8EB2A3Q47236224-C8339C97-4D4B-4A08-AA39-EEFB695EA92DQ48304270-152641CD-73EC-45EC-A9A5-C6BC7E21E6B2Q48442839-BC86DB2F-2949-46CE-876B-5EA4C5B8B5FFQ49123495-2C075625-166B-4C61-BBB3-2215F30120E0Q51822950-3FA27B68-CC6F-4EBF-B90B-F662913829CD
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Gray-matter injury in multiple sclerosis.
@en
Gray-matter injury in multiple sclerosis.
@nl
type
label
Gray-matter injury in multiple sclerosis.
@en
Gray-matter injury in multiple sclerosis.
@nl
prefLabel
Gray-matter injury in multiple sclerosis.
@en
Gray-matter injury in multiple sclerosis.
@nl
P356
P1476
Gray-matter injury in multiple sclerosis.
@en
P2093
Bruce D Trapp
Richard A Rudick
P304
P356
10.1056/NEJMCIBR0905482
P407
P577
2009-10-01T00:00:00Z